Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$3.25B |
| 2 |
Broadcom
AVGO
|
+$1.15B |
| 3 |
Netflix
NFLX
|
+$1.1B |
| 4 |
Truist Financial
TFC
|
+$1.07B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.07B |
Top Sells
| 1 |
Intel
INTC
|
+$1.46B |
| 2 |
UnitedHealth
UNH
|
+$1.38B |
| 3 |
Coca-Cola
KO
|
+$1.24B |
| 4 |
Merck
MRK
|
+$905M |
| 5 |
Fiserv
FI
|
+$904M |
Sector Composition
| 1 | Technology | 20.93% |
| 2 | Healthcare | 18.46% |
| 3 | Communication Services | 14.42% |
| 4 | Financials | 11.83% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Cousins Properties
CUZ
$4.89B
| $17.5M | 0.01% |
599,532
+72,800
| +14% | +$2.13M |
|
327
Credicorp
BAP
$21.2B
| $17.5M | 0.01% |
122,200
| – | – |
|
|
CVA
328
DELISTED
Covanta Holding Corporation
CVA
| $17.3M | 0.01% |
2,019,800
| – | – |
|
|
RVNC
329
DELISTED
Revance Therapeutics, Inc.
RVNC
| $17.2M | 0.01% |
1,161,900
| – | – |
|
330
Phreesia
PHR
$1.38B
| $16.2M | 0.01% |
768,500
+368,500
| +92% | +$7.75M |
|
331
Yeti Holdings
YETI
$2.82B
| $15.2M | 0.01% |
780,700
+336,564
| +76% | +$6.57M |
|
332
Newell Brands
NWL
$2.42B
| $15.1M | 0.01% |
1,137,800
-587,200
| -34% | -$7.8M |
|
|
OCFT
333
OneConnect Financial Technology
OCFT
$282M
| $14.9M | 0.01% |
146,613
+10,743
| +8% | +$1.09M |
|
334
Yext
YEXT
$1.07B
| $14.8M | 0.01% |
1,454,400
| – | – |
|
335
Cactus
WHD
$2.75B
| $14.5M | 0.01% |
1,249,900
| – | – |
|
336
Sarepta Therapeutics
SRPT
$1.91B
| $14.2M | 0.01% |
+144,728
| New | +$14.2M |
|
337
Wyndham Hotels & Resorts
WH
$6.43B
| $14.1M | 0.01% |
446,900
-1,345,579
| -75% | -$42.4M |
|
338
Flex
FLEX
$21.3B
| $13.9M | 0.01% |
2,202,157
| – | – |
|
339
Evertec
EVTC
$2.13B
| $13.6M | 0.01% |
599,690
+200,390
| +50% | +$4.55M |
|
340
Pool Corp
POOL
$12.1B
| $13.6M | 0.01% |
68,900
-78,100
| -53% | -$15.4M |
|
341
KT
KT
$9.66B
| $13.5M | 0.01% |
1,728,807
+2,024
| +0.1% | +$15.7K |
|
|
CLLS
342
Cellectis
CLLS
$308M
| $12.9M | 0.01% |
1,405,236
+389,300
| +38% | +$3.58M |
|
343
PPL Corp
PPL
$26.4B
| $12.9M | 0.01% |
523,133
| – | – |
|
344
Fair Isaac
FICO
$37.4B
| $12.8M | 0.01% |
41,700
-88,875
| -68% | -$27.3M |
|
345
UBS Group
UBS
$131B
| $12.6M | 0.01% |
1,343,666
| – | – |
|
346
Xenon Pharmaceuticals
XENE
$2.77B
| $12M | ﹤0.01% |
1,055,726
| – | – |
|
347
Endava
DAVA
$519M
| $11.3M | ﹤0.01% |
322,200
| – | – |
|
348
IAC Inc
IAC
$2.91B
| $10.8M | ﹤0.01% |
335,724
-1,643,372
| -83% | -$52.6M |
|
|
NLSN
349
DELISTED
Nielsen Holdings plc
NLSN
| $10.7M | ﹤0.01% |
856,400
| – | – |
|
|
SILK
350
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $10.1M | ﹤0.01% |
+320,600
| New | +$10.1M |
|